Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CHUGAI PHARMACEUTICAL CO., LTD.

(4519)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société CHUGAI PHARMACEUTICAL CO., LTD.
09/13CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
08/30CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
08/25CHUGAI PHARMACEUTICAL : Presentation
PU
08/12CHUGAI PHARMACEUTICAL : Launches Evrysdi Dry Syrup 60 mg for the Treatment of Spinal Muscu..
PU
08/02CHUGAI PHARMACEUTICAL : Launches FoundationOne Liquid CDx Cancer Genomic Profile as the Fi..
PU
07/30CHUGAI PHARMACEUTICAL : Continues to be Listed for All ESG Indices Selected by GPIF
PU
07/28CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
07/26CHUGAI PHARMACEUTICAL : CONSOLIDATED FINANCIAL STATEMENTS (IFRS)(Non-Audited)(for the seco..
PU
07/26CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Results for the..
PU
07/26CHUGAI PHARMACEUTICAL : Construction of API Manufacturing Building for Late Stage Clinical..
PU
07/26CHUGAI PHARMACEUTICAL : Announces 2021 Half Year Results
PU
07/26CHUGAI PHARMACEUTICAL : Organizational and Personnel Changes
PU
07/26CHUGAI PHARMACEUTICAL : Presentation
PU
07/25CHUGAI PHARMACEUTICAL : F. Hoffmann-La Roche Announces Half Year Results 2021
PU
07/21CHUGAI PHARMACEUTICAL : 2Q Results (Jan-Jun 2021)
PU
07/21CHUGAI PHARMACEUTICAL : Supplementary Materials
PU
07/20CHUGAI PHARMACEUTICAL : Antibody Cocktail, RONAPREVE for Intravenous Infusion Set Receives..
AQ
07/20ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with haemophilia ..
AQ
07/19CHUGAI PHARMACEUTICAL : The Antibody Cocktail, RONAPREVE for Intravenous Infusion Set Rece..
PU
07/19CHUGAI PHARMACEUTICAL : The Antibody Cocktail, RONAPREVE for Intravenous Infusion Set Rece..
PU
07/19ROCHE : New data for Roche's Hemlibra reinforce safety profile in people with haemophilia ..
AQ
07/15CHUGAI PHARMACEUTICAL : Released Short Film Featuring Mayu Hotta and Nami Kishida 'I Wante..
AQ
07/14CHUGAI PHARMACEUTICAL : Released Short Film Featuring Mayu Hotta and Nami Kishida “I..
PU
07/12CHUGAI PHARMACEUTICAL : and Alebund Enter into Option and License Agreement for EOS789 und..
AQ
07/09CHUGAI PHARMACEUTICAL : Disposal of Vaccines for Workplace Vaccination
AQ
07/09CHUGAI PHARMACEUTICAL : and Alebund Enter into Option and License Agreement for EOS789 und..
PU
07/08CHUGAI PHARMACEUTICAL : Disposal of Vaccines for Workplace Vaccination
PU
07/08CHUGAI PHARMACEUTICAL : Files for Additional Indication of Tecentriq for the Adjuvant Trea..
AQ
06/29CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission as First A..
AQ
06/29CHUGAI PHARMACEUTICAL : Files New Drug Application in Japan for Antibody Cocktail Casirivi..
PU
06/28CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission as First A..
PU
06/28CHUGAI PHARMACEUTICAL : Enspryng (Satralizumab) Approved by European Commission as First A..
BU
06/25CHUGAI PHARMACEUTICAL : Genentech Announces FDA Emergency Use Authorization for Chugai's A..
AQ
06/25CHUGAI PHARMACEUTICAL : and ALBERT Jointly Develop Data Scientist Training Program for Pha..
PU
06/25CHUGAI PHARMACEUTICAL : Immunosuppressant CellCept, Approved for Additional Indication of ..
PU
06/23CHUGAI PHARMACEUTICAL : Obtains Regulatory Approval for Evrysdi for the Treatment of Spina..
PU
06/22CHUGAI PHARMACEUTICAL : Obtains Regulatory Approval for FoundationOne CDx Cancer Genomic P..
PU
06/14CHUGAI PHARMACEUTICAL : Files New Drug Application in Japan for Faricimab, the First Bispe..
AQ
06/11CHUGAI PHARMACEUTICAL : Files New Drug Application in Japan for Faricimab, the First Bispe..
PU
06/07CHUGAI PHARMACEUTICAL : Selected as Digital Transformation Stock (DX Stock) 2021
PU
06/02CHUGAI PHARMACEUTICAL : Presentation
PU
05/30CHUGAI PHARMACEUTICAL : Introduces First Cryo-electron Microscopy System in Pharmaceutical..
PU
05/27CHUGAI PHARMACEUTICAL : Main Report
PU
05/20CHUGAI PHARMACEUTICAL : Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profi..
PU
05/19CHUGAI PHARMACEUTICAL : Launches Polivy Intravenous Infusion for the Treatment of Diffuse ..
PU
05/10CHUGAI PHARMACEUTICAL : Discontinues Marketing of Photodynamic Diagnostic Agent 'ALAGLIO D..
AQ
05/10CHUGAI PHARMACEUTICAL : Reached Agreement with Japanese Government regarding Investigation..
PU
05/09CHUGAI PHARMACEUTICAL : Discontinues Marketing of Photodynamic Diagnostic Agent "ALAGLIO® ..
PU
05/05CHUGAI PHARMACEUTICAL : Research Collaboration by Chugai, the University of Tokyo and RIKE..
PU
04/26CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
04/25CHUGAI PHARMACEUTICAL : CHMP recommends EU approval of Chugai's Enspryng (Satralizumab) fo..
PU
04/25CHUGAI PHARMACEUTICAL : CHMP Recommends EU Approval of Chugai's Enspryng (Satralizumab) fo..
BU
04/22CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise 2030 Gree..
AQ
04/22CHUGAI PHARMACEUTICAL : Announces 2021 1st Quarter Results
PU
04/22CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Results for the..
PU
04/22CHUGAI PHARMACEUTICAL : CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the fir..
PU
04/21CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted ..
PU
04/21CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise 2030 Gree..
PU
04/21CHUGAI PHARMACEUTICAL : F. Hoffmann-La Roche Announces First Quarter Sales 2021
PU
04/12CHUGAI PHARMACEUTICAL : Roche Announces Results of Phase 3 Study for Investigational Antib..
PU
04/09CHUGAI PHARMACEUTICAL : Conducts Disease Awareness Activities Internally and Externally in..
AQ
04/07CHUGAI PHARMACEUTICAL : Conducts Disease Awareness Activities Internally and Externally in..
PU
04/01CHUGAI PHARMACEUTICAL : Mar 31, 2021Chugai Organizes the Second Workshop on Multidisciplin..
AQ
03/31CHUGAI PHARMACEUTICAL : Organizes the Second Workshop on Multidisciplinary Team Care Onlin..
PU
03/24CHUGAI PHARMACEUTICAL : Position and Policy Regarding Reduction of the Investment Unit
AQ
03/24CHUGAI PHARMACEUTICAL : Obtains Approval for Polivy for the Treatment of Relapsed or Refra..
AQ
03/24CHUGAI PHARMACEUTICAL : Notice of Disposal of Treasury Shares as Restricted Stock Compensa..
AQ
03/24CHUGAI PHARMACEUTICAL : Voting Results (Extraordinary Report) of the 110th Annual General ..
PU
03/23CHUGAI PHARMACEUTICAL : Selected as a 'Nadeshiko Brand'
AQ
03/23CHUGAI PHARMACEUTICAL : Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profi..
PU
03/23CHUGAI PHARMACEUTICAL : Position and Policy Regarding Reduction of the Investment Unit
PU
03/23CHUGAI PHARMACEUTICAL : Notice of Disposal of Treasury Shares as Restricted Stock Compensa..
PU
03/22CHUGAI PHARMACEUTICAL : Performance of Chugai's AI-based Antibody Discovery Technology MAL..
PU
03/22CHUGAI PHARMACEUTICAL : Selected as a “Nadeshiko Brand” --The proactive approa..
PU
03/12Chugai Provides Update on the Phase III REMDACTA Study of Actemra Plus Remdesivir in Pa..
AQ
1  2  3  4  5  6Next
Upcoming event on CHUGAI PHARMACEUTICAL CO., LTD.